×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Pasithea Therapeutics Corp. (KTTA) NASDAQ

$5.26 (0.44) (-7.71%)

Market Cap: $5.49M

As of 06/14/24 04:30 PM EDT. Market closed.

(KTTA)

Pasithea Therapeutics Corp. (KTTA)
NASDAQ

$5.26
(0.44) (-7.71%)

Market Cap: $5.49M

As of 06/14/24 04:30 PM EDT. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
PRICE CHART FOR PASITHEA THERAPEUTICS CORP
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$5.70
Days Range
$5.26 - $5.40
52 week range
$5.25 - $17.40
Volume
3,585
Avg. Volume (30 days)
6,541
Market Cap
$5.49M
Dividend Yield
-
P/E
(0.34)
Shares Outstanding
1,043,248
Open
-
Previous Close
$5.70
Days Range
$5.26 - $5.40
52 week range
$5.25 - $17.40
Volume
3,585
Avg. Volume (30 days)
6,541
Market Cap
$5.49M
Dividend Yield
-
P/E
(0.34)
Shares Outstanding
1,043,248
FINANCIAL STATEMENTS FOR PASITHEA THERAPEUTICS CORP
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR PASITHEA THERAPEUTICS CORP
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Novak Alfred JDirectorJun 13, 2024 Option Exercise$5.622,75015,4553,500Jun 14, 2024, 05:25 PM
Novak Alfred JDirectorJun 12, 2024 Option Exercise$5.617504,208750Jun 14, 2024, 05:25 PM
STEINMAN LAWRENCEDirectorJun 02, 2023 Buy$0.4330,00012,9301,327,174Jun 06, 2023, 09:00 PM
STEINMAN LAWRENCEDirectorNov 28, 2022 Option Exercise$0.985,0004,9001,287,174Nov 28, 2022, 04:00 PM
Marques TiagoChief Executive OfficerNov 25, 2022 Option Exercise$1.032,0002,060819,206Nov 28, 2022, 04:00 PM
Marques TiagoChief Executive OfficerNov 23, 2022 Option Exercise$1.017,2067,260817,206Nov 28, 2022, 04:00 PM
STEINMAN LAWRENCEDirectorNov 22, 2022 Option Exercise$0.995,0004,9501,282,174Nov 22, 2022, 04:10 PM
Dumesnil SimonDirectorNov 15, 2022 Option Exercise$1.0710,00010,70010,000Nov 17, 2022, 04:34 PM
Dumesnil SimonDirectorNov 17, 2022 Option Exercise$1.0640,00042,40050,000Nov 17, 2022, 04:34 PM
STEINMAN LAWRENCEDirectorOct 26, 2022 Option Exercise$1.105,0005,5001,277,174Oct 26, 2022, 05:35 PM
Marques TiagoChief Executive OfficerOct 21, 2022 Option Exercise$1.075,0005,356810,000Oct 21, 2022, 05:05 PM
Delaney DavidMember of 10% owner groupOct 17, 2022 Buy$1.111,0001,110227,521Oct 19, 2022, 05:29 PM
STEINMAN LAWRENCEDirectorOct 17, 2022 Option Exercise$1.1310,00011,3101,272,174Oct 17, 2022, 06:11 PM
Shahinian EricMember of 10% owner groupSep 29, 2022 Buy$1.166,7107,7571,788,415Sep 30, 2022, 04:36 PM
Shahinian EricMember of 10% owner groupSep 28, 2022 Buy$1.1957,64768,5421,781,705Sep 30, 2022, 04:36 PM
Shahinian EricMember of 10% owner groupSep 06, 2022 Buy$1.1321,74824,6321,724,058Sep 06, 2022, 05:03 PM
Shahinian EricMember of 10% owner groupSep 02, 2022 Buy$1.1411,50713,1051,702,310Sep 06, 2022, 05:03 PM
Shahinian EricMember of 10% owner groupSep 01, 2022 Buy$1.1355,64662,6301,690,803Sep 06, 2022, 05:03 PM
Shahinian EricMember of 10% owner groupAug 30, 2022 Buy$1.1517,82820,4521,635,157Aug 31, 2022, 04:32 PM
Shahinian EricMember of 10% owner groupAug 29, 2022 Buy$1.175,0005,8401,617,329Aug 31, 2022, 04:32 PM
Geller AviMember of 10% owner groupAug 19, 2022 Buy$1.3054,64470,93954,644Aug 26, 2022, 04:30 PM
Shahinian EricMember of 10% owner groupAug 17, 2022 Buy$1.21155,773188,2831,611,329Aug 18, 2022, 07:35 PM
STEINMAN LAWRENCEDirectorJun 29, 2022 Option Exercise$1.005,0005,0001,272,174Jun 30, 2022, 04:15 PM
STEINMAN LAWRENCEDirectorJun 28, 2022 Option Exercise$1.025,0005,1001,267,174Jun 30, 2022, 04:15 PM
STEINMAN LAWRENCEDirectorJun 27, 2022 Option Exercise$1.005,0005,0001,262,174Jun 27, 2022, 04:15 PM
Marques TiagoChief Executive OfficerJun 23, 2022 Option Exercise$0.995,0004,964805,000Jun 23, 2022, 05:10 PM
STEINMAN LAWRENCEDirectorJun 23, 2022 Option Exercise$1.005,0005,0001,257,174Jun 23, 2022, 04:31 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Novak Alfred JDirector06/13/202415,455
Novak Alfred JDirector06/12/20244,208
STEINMAN LAWRENCEDirector06/02/202312,930
STEINMAN LAWRENCEDirector11/28/20224,900
Marques TiagoChief Executive Officer11/25/20222,060
Marques TiagoChief Executive Officer11/23/20227,260
STEINMAN LAWRENCEDirector11/22/20224,950
Dumesnil SimonDirector11/15/202210,700
Dumesnil SimonDirector11/17/202242,400
STEINMAN LAWRENCEDirector10/26/20225,500
Marques TiagoChief Executive Officer10/21/20225,356
Delaney DavidMember of 10% owner group10/17/20221,110
STEINMAN LAWRENCEDirector10/17/202211,310
Shahinian EricMember of 10% owner group09/29/20227,757
Shahinian EricMember of 10% owner group09/28/202268,542
Shahinian EricMember of 10% owner group09/06/202224,632
Shahinian EricMember of 10% owner group09/02/202213,105
Shahinian EricMember of 10% owner group09/01/202262,630
Shahinian EricMember of 10% owner group08/30/202220,452
Shahinian EricMember of 10% owner group08/29/20225,840
Geller AviMember of 10% owner group08/19/202270,939
Shahinian EricMember of 10% owner group08/17/2022188,283
STEINMAN LAWRENCEDirector06/29/20225,000
STEINMAN LAWRENCEDirector06/28/20225,100
STEINMAN LAWRENCEDirector06/27/20225,000
Marques TiagoChief Executive Officer06/23/20224,964
STEINMAN LAWRENCEDirector06/23/20225,000
Load More Insider Transactions
FUNDS WITH A POSITION IN PASITHEA THERAPEUTICS CORP
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC125,1230.00001%ExitedOther
RENAISSANCE TECHNOLOGIES LLC32,5000.00002%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR PASITHEA THERAPEUTICS CORP
STOCK BUYBACKS FOR PASITHEA THERAPEUTICS CORP
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
0.35%
1Q
03/31/2024
12/31/2021
-89.98%
9Q
03/31/2024
09/30/2021
-88.36%
10Q
03/31/2024
06/30/2021
-87.38%
11Q
03/31/2024
03/31/2021
-86.89%
12Q
03/31/2024
12/31/2020
-86.03%
13Q
03/31/2024
09/30/2020
-85.74%
14Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
0.35%
1Q
12/31/2021
-89.98%
9Q
09/30/2021
-88.36%
10Q
06/30/2021
-87.38%
11Q
03/31/2021
-86.89%
12Q
12/31/2020
-86.03%
13Q
09/30/2020
-85.74%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PASITHEA THERAPEUTICS CORP
LOADING...